Thanks inv, the next question to ask would, therefore, be: How do they propose to raise the money to fund another trial? We will run out of capital before any other trial is due to start, so having the opportunity to use the $2.7M for another trial is moot at this point in time.
Interesting article on GT and pharma, page-17
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)